After $3 million worth of Kratom is seized, FDA continued to warn of its dangers
In an import warning that has been in effect for many years, the FDA has determined that Kratom and dietary supplements containing this herb are adulterated.
Mithragina, commonly known as Kratom, is a plant that grows as a shrub or small tree. It is native to Thailand, Malaysia, Indonesia, and Papua New Guinea. In recent years, this plant has gained a following due to its alleged pain control effect and its ability to help people quit the use of opioids.

Because kratom acts on opioid receptors in the same way as opioid itself, the Drug Enforcement Administration (DEA) has always considered that this substance has the risk of addiction. This plant is not classified as a controlled drug, but the Anti Drug Administration lists it as a "drug of concern and chemical."
Dr. Judy McMeekin, Deputy Director of Regulatory Affairs at the US Food and Drug Administration, said at a press conference at the US Department of Justice, "This lockdown highlights our commitment to take proactive action when companies sell products containing dangerous ingredients such as Kratom. We will continue to protect consumers from illegal sales of products that do not comply with FDA regulations.”

A 2022 study found that nearly one-third of people in the United States who use Kratom meet the criteria for Kratom use disorders, including tolerance, withdrawal, smoking cessation failure, and craving. In recent years, research has also linked Kratom with liver injury and death, but it has also been recognized that this plant is a safer pain treatment option than opioid drugs. A review published in the Journal of Clinical Pharmacology in 2021 found that compared to traditional opioid drugs, Kratom can alleviate pain, cause mild euphoria, and have a lower risk of adverse effects on the respiratory and nervous systems. However, its use is associated with hepatotoxicity, seizures and death. A 2020 study also found that Kratom users in the United States are generally more likely to abuse drugs than those who use marijuana, alcohol, or cigarettes.
“If it is ever studied to a point that the FDA puts its thumb of approval on it, it will be in a purified form and there will be data that shows its safety, “ Saids Dr. Alan Kaye, a professor of anesthesiology and pharmacology at LSU in Shreveport, Louisiana.
Currently, the US Food and Drug Administration continues to advise people not to take Kratom.
Looking for chemical products? Let suppliers reach out to you!
2026-07-03
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA issues new guidelines, accelerating the development of personalized medicine
-
CYNiO Receives Over €2 Million for the NextInnovation in the Specialty Chemicals Industry
-
Eastman and Huafon Chemical to Establish Cellulose Acetate Yarn Production Plant in China
-
Sinopec and Saudi Aramco Launch $10 Billion Joint Venture, Accelerating Gulei Refining and Petrochemical Phase II Project
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
BASF Strengthens Its Liquid Enzyme Portfolio for Laundry and Cleaning Industries
-
Kemira to Expand Drinking Water Treatment Portfolio with New ACH Production Line
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Clariant and Shanghai Electric Partner to Advance Biomass-Based Green Methanol in China
Recommend Reading
-
Avril Group to Acquire Champlor Renewables from Valtris
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Air Liquide's Molybdenum Manufacturing Plant in South Korea is Operational
-
Bakelite Acquires Sestec, Strengthening Bio-Based Adhesives Offering
-
Wacker Invests 300 Million Euros in New Semiconductor-Grade Polysilicon Production Line in Germany
-
Röhm Shuts 150,000-Ton MMA Plant in Louisiana as 250,000-Ton Bay City Facility Ramps Up Prices Fall 14.5 Percent
-
Cost support strong, anhydrous hydrogen fluoride market remains firm and tends to strengthen (12.22-12.26)
-
80 Percent Beat Expectations 2025 H1 Earnings Previews Show China’s Chemical Sector Rebounds
-
Qatar Launches 350,000-Ton PVC Plant in September Europe Braces for More Imports Amid Market Turmoil
-
Brazil Proposes Major Food Additive Rule Changes 2200 mg/kg Phosphate Limit and New Plant-Based Approvals